This information was published on 2025-09-28T00:05:08 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2547895 (IR 1826430) |
| (220) |
27 Apr 2025
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of cardiovascular diseases. |
| (540) | Glemway |
| (550) | Word |
| (730) |
Novo Nordisk A/S
|
Find out more about publications on the About page.